Raghunath M, Kielty C M, Kainulainen K, Child A, Peltonen L, Steinmann B
Department of Paediatrics, University of Zürich, Switzerland.
Biochem J. 1994 Sep 15;302 ( Pt 3)(Pt 3):889-96. doi: 10.1042/bj3020889.
We studied fibrillin synthesis in cultured fibroblasts from 11 members of a three-generation family with Marfan syndrome, caused by a large in-frame deletion in FBN1 (the fibrillin gene) leading to a loss of 366 bases in the corresponding fibrillin mRNA. Metabolic labelling with [35S]Met/Cys and SDS/PAGE allowed unequivocal identification of normal and truncated fibrillin in all cell strains harbouring the deletion. In culture medium, fibrillin and its truncated counterpart were predominant, whereas their respective larger precursors were found only in traces. This proportion, however, was markedly shifted towards the normal and truncated precursors by EGTA and reversed by the addition of calcium, which confirmed the existence of profibrillin and its probably calcium-dependent conversion into fibrillin. Tunicamycin caused increased electrophoretic mobility of normal and truncated molecules without changing their apparent size differences. Intracellularly, only profibrillin was found; in the mutant cells truncated and normal profibrillin molecules were present in similar amounts and both populations were secreted and deposited simultaneously into the extracellular matrix; there, however, truncated profibrillin only became easily detectable after treatment of cells with dextran sulphate, which increased the amount of extractable profibrillin. Immunofluorescence microscopy in patients' cultures identified fibrillin-containing microfibrils which appeared to be moderately reduced both in amount and diameter. Ultrastructural analysis by rotary-shadowing and immunogold electron microscopy demonstrated the presence of numerous beaded domains reacting with fibrillin antibodies, but no intact fibrillin microfibrils in patient's cell-layer extracts, in contrast with the extensive microfibrils elaborated by control cultures. Our findings suggest, that in the patients' cell cultures all microfibrils contained the truncated fibrillin molecules.
我们研究了来自一个患有马凡综合征的三代家族中11名成员的培养成纤维细胞中的原纤蛋白合成情况。该综合征由FBN1(原纤蛋白基因)中的一个大的框内缺失引起,导致相应原纤蛋白mRNA中366个碱基的缺失。用[35S]甲硫氨酸/半胱氨酸进行代谢标记和SDS/PAGE能够明确鉴定出所有携带该缺失的细胞株中的正常和截短的原纤蛋白。在培养基中,原纤蛋白及其截短的对应物占主导,而它们各自较大的前体仅以痕量存在。然而,EGTA使这一比例明显向正常和截短的前体转移,而添加钙则使其逆转,这证实了原纤蛋白原的存在及其可能依赖钙向原纤蛋白的转化。衣霉素导致正常和截短分子的电泳迁移率增加,而不改变它们明显的大小差异。在细胞内,仅发现了原纤蛋白原;在突变细胞中,截短的和正常的原纤蛋白原分子以相似的量存在,并且这两种群体同时被分泌并沉积到细胞外基质中;然而,在用硫酸葡聚糖处理细胞后,截短的原纤蛋白原才变得易于检测,这增加了可提取的原纤蛋白原的量。患者培养物中的免疫荧光显微镜检查鉴定出含有原纤蛋白的微原纤维,其数量和直径似乎都有适度减少。通过旋转阴影和免疫金电子显微镜进行的超微结构分析表明,存在许多与原纤蛋白抗体反应的串珠状结构域,但在患者细胞层提取物中没有完整的原纤蛋白微原纤维,这与对照培养物中形成的广泛微原纤维形成对比。我们的研究结果表明,在患者的细胞培养物中,所有微原纤维都含有截短的原纤蛋白分子。